Convergent Therapeutics Funding: $90M Raised, Series A
Convergent Therapeutics is based in Cambridge, Massachusetts. It has raised $90M in total funding. Latest round: Series A.
Convergent Therapeutics funding overview
Convergent Therapeutics is based in Cambridge, Massachusetts. Convergent Therapeutics has raised $90M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in April 2023. The round record for Convergent Therapeutics runs through 2023; nothing later has been disclosed.
Convergent Therapeutics at a glance
Total raised
$90M
Latest round
Series A
Latest round date
April 2023
Headquarters
Cambridge, Massachusetts
Frequently asked about Convergent Therapeutics funding
How much has Convergent Therapeutics raised?
Convergent Therapeutics has raised $90M in total disclosed funding across the rounds on record.
Who has invested in Convergent Therapeutics?
No investors are named on the public record for Convergent Therapeutics yet.
What was the latest Convergent Therapeutics funding round?
The most recent disclosed round is a Series A, announced in April 2023.
Where is Convergent Therapeutics based?
Convergent Therapeutics is based in Cambridge, Massachusetts.
When did Convergent Therapeutics last raise?
The last disclosed Convergent Therapeutics round closed in April 2023 at Series A.
Every Convergent Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Cambridge at a similar stage.
